Paul K. Wotton, PhD

Chief Executive Officer

Paul Wotton is an accomplished leader in the biotechnology and pharmaceutical industry with experience spanning scientific research, product development and corporate growth gained over a thirty-year career. Dr. Wotton most  MORE >

Tariq Kassum, MD

Chief Operating Officer and Head of Corporate Development

Tariq Kassum is Chief Operating Officer and Head of Corporate Development at Obsidian Therapeutics and was a member of the company’s founding team. Previously he was Vice President, Business Development and  MORE >

Steve Shamah, PhD

Senior Vice President and Head of Research

Steve Shamah joined Obsidian Therapeutics in September 2016 as Senior Vice President and Head of Research where he leads a dynamic team towards the discovery and development of next generation cell  MORE >

Vipin Suri, PhD

Vice President, Discovery

Vipin Suri is the VP of Discovery at Obsidian Therapeutics and joined Obsidian’s founding team in January of 2016. Prior to Joining Obsidian, Vipin was Head of Biology at Raze Therapeutics  MORE >

Celeste Richardson, PhD

Vice President, Cell Therapy

Celeste Richardson joined Obsidian Therapeutics in November of 2016 as Vice President of Cell Therapy.  Prior to joining Obsidian, Celeste was at the Novartis Institutes for Biomedical Research where she led  MORE >

Mike Briskin, PhD

Senior Advisor, Research

Mike Briskin is Senior Advisor at Obsidian Therapeutics.Dr. Briskin brings more than 20 years of industry experience in multiple areas of drug discovery, including molecular biology, immunobiology, oncology and inflammation. Prior to  MORE >

We would like to collect information during your visit to help us better understand site use. This data is anonymized, and will not be used for marketing purposes. Read More on our Privacy Policy page. You can withdraw permission at any time or update your privacy settings here. Please choose below to continue.

Yes, I agree No, Please do not